Insider Shareholders with Direct Ownership of Protara Therapeutics, Inc. (TARA)
This section provides a comprehensive overview of the insiders with direct ownership of Protara Therapeutics, Inc. (TARA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Protara Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jesse Shefferman
CEO and President |
161,665 | 59,870 | 935,501 $2.16 Million | 14 |
Aug 28, 2024
Reduced 0.35%
|
| 30,000 | 0 | 198,000 $457,380 | 3 |
Jun 30, 2022
Added 4.81%
|
|
|
Jacqueline Zummo
Chf Scientific Operations Off |
57,000 | 26,817 | 104,296 $240,923 | 10 |
Jan 19, 2024
Reduced 2.84%
|
|
Jathin Bandari
Chief Medical Officer |
57,200 | 7,996 | 56,704 $130,986 | 8 |
Jan 19, 2024
Reduced 4.83%
|
|
Hannah Fry
VP, Controller |
38,900 | 11,664 | 29,836 $68,921 | 7 |
Jan 19, 2024
Reduced 2.94%
|
|
Patrick Fabbio
Chief Financial Officer |
22,000 | 0 | 22,000 $50,820 | 1 |
Jan 19, 2024
Added 50.0%
|
|
Blaine Davis
Chief Financial Officer |
14,100 | 5,081 | 20,662 $47,729 | 2 |
Jul 15, 2022
Reduced 19.74%
|
|
Martin Sebastian Olivo
Chief Medical Officer |
9,893 | 0 | 14,344 $33,134 | 1 |
Jun 10, 2021
Added 25.59%
|